LGC
TMO icon

Laurel Grove Capital’s Thermo Fisher Scientific TMO Stock Holding History

Laurel Grove Capital’s Portfolio TMO Stock Details TMO Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-2,950
Closed -$396K – 106
2015
Q1 		$396K Buy
2,950
+1,050
+55% +$135K 0.21% 80
2014
Q4 		$238K Buy
+1,900
New +$231K 0.14% 90

Other funds holding TMO

Massachusetts Financial Services
Massachusetts Financial Services Boston, Massachusetts $298B AUM 21.96% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $645B AUM 30.41% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
Capital World Investors
Capital World Investors Los Angeles, California $733B AUM 35.63% 1-Year Est. Return
GCM
Glenview Capital Management New York $3.98B AUM 20.52% 1-Year Est. Return
Primecap Management
Primecap Management Pasadena, California $127B AUM 44.11% 1-Year Est. Return

Laurel Grove Capital's TMO Position: Q2 2015 in Review

Laurel Grove Capital sold out of Thermo Fisher Scientific (TMO) in Q2 2015, closing a stake of 2,950 shares — an estimated $396K sold.

Laurel Grove Capital first reported a position in TMO in Q4 2014 and held it in 2 quarters. The position peaked at $396K in Q1 2015. 974 funds tracked by Wall St. Rank hold TMO as of Q2 2015.

  • Laurel Grove Capital reported no remaining Thermo Fisher Scientific position as of Q2 2015 after selling out during the quarter.
  • Laurel Grove Capital sold 2,950 Thermo Fisher Scientific shares in Q2 2015, an estimated $396K.
  • Laurel Grove Capital first reported a position in Thermo Fisher Scientific in Q4 2014 and held it in 2 quarters.
  • Laurel Grove Capital's Thermo Fisher Scientific position peaked at $396K in Q1 2015.
  • 974 funds tracked by Wall St. Rank held Thermo Fisher Scientific as of Q2 2015.

Based on Laurel Grove Capital's 13F filing for Q2 2015, filed 14 Jul 2015.